Archive
Year
2022 - 2021
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
Orvacabtagene autoleucel (orva-cel), a Bcell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011)
JOURNAL OF CLINICAL ONCOLOLOGY
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 48